Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 29, 2022

Treatment and Survival Patterns in Patients With Stage II/III Rectal Cancer Receiving Trimodality Therapy

JAMA Oncology

 

Additional Info

JAMA Oncology
Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy
JAMA Oncol 2022 Aug 18;[EPub Ahead of Print], HF Kennecke, HT Bahnson, B Lin, C O'Rourke, J Kaplan, H Pham, A Suen, VV Simianu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading